2023 finished with an impressive 46% y/y growth and EBIT margin of 29%, in our view indicative of the long-term profitability potential. With the recent strong momentum and adding to that the planned launch of SyMRI 3D in 2024, we expect the growth continue, and view the sales target implying 23% y/y as achievable. We raise our near-term sales estimate by 2%, but lower EBIT margins, and our fair value range of SEK 26-31 is unchanged.

Länk till analysen